| dbo:abstract
|
- Estradiol valerate/prasterone enanthate (EV/DHEA-E), sold under the brand name Gynodian Depot among others, is an injectable combination medication of estradiol valerate (EV), an estrogen, and prasterone enanthate (DHEA-E), an androgen, estrogen, and neurosteroid, which is used in menopausal hormone therapy for women. It is provided in the form of 1 mL ampoules containing 4 mg estradiol valerate and 200 mg prasterone enanthate in an oil solution and is administered by intramuscular injection once every 4 to 6 weeks. EV/DHEA-E reportedly has a duration of about 21 days. The medication is available in Europe, Latin America, and Egypt. EV/DHEA-E was developed and marketed by Schering, was first described in the literature in 1972, and was introduced for medical use in April 1975. (en)
|
| dbo:alternativeName
|
- Gynodian Depot, Binodian Depot, Cidodian Depot, Klimax, Supligol NF (en)
|
| dbo:casNumber
| |
| dbo:fdaUniiCode
| |
| dbo:pubchem
| |
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 11636 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:caption
| |
| dbp:casNumber
|
- 979 (xsd:integer)
- 23983 (xsd:integer)
|
| dbp:class
| |
| dbp:component
|
- Estradiol valerate (en)
- Prasterone enanthate (en)
|
| dbp:drugName
|
- Estradiol valerate / (en)
- prasterone enanthate (en)
|
| dbp:image
|
- Prasterone enanthate.svg (en)
|
| dbp:pubchem
| |
| dbp:routesOfAdministration
| |
| dbp:synonyms
|
- EV/DHEA-E; EV/PE; SH-70833-D (en)
|
| dbp:title
| |
| dbp:titlestyle
| |
| dbp:tradename
|
- Gynodian Depot, Binodian Depot, Cidodian Depot, Klimax, Supligol NF (en)
|
| dbp:type
| |
| dbp:unii
|
- 2 (xsd:integer)
- OKG364O896 (en)
|
| dbp:width
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Estradiol valerate/prasterone enanthate (EV/DHEA-E), sold under the brand name Gynodian Depot among others, is an injectable combination medication of estradiol valerate (EV), an estrogen, and prasterone enanthate (DHEA-E), an androgen, estrogen, and neurosteroid, which is used in menopausal hormone therapy for women. It is provided in the form of 1 mL ampoules containing 4 mg estradiol valerate and 200 mg prasterone enanthate in an oil solution and is administered by intramuscular injection once every 4 to 6 weeks. EV/DHEA-E reportedly has a duration of about 21 days. (en)
|
| rdfs:label
|
- Estradiol valerate/prasterone enanthate (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Estradiol valerate / (en)
- prasterone enanthate (en)
|
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
